» Articles » PMID: 37373513

Glymphatic System and Mitochondrial Dysfunction As Two Crucial Players in Pathophysiology of Neurodegenerative Disorders

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2023 Jun 28
PMID 37373513
Authors
Affiliations
Soon will be listed here.
Abstract

Neurodegenerative diseases are a complex problem affecting millions of people around the world. The pathogenesis is not fully understood, but it is known that both insufficiency of the glymphatic system and mitochondrial disorders affect the development of pathology. It appears that these are not just two independent factors that coexist in the processes of neurodegeneration, but that they often interact and drive each other. Bioenergetics disturbances are potentially associated with the accumulation of protein aggregates and impaired glymphatic clearance. Furthermore, sleep disorders characteristic of neurodegeneration may impair the work of both the glymphatic system and the activity of mitochondria. Melatonin may be one of the elements linking sleep disorders with the function of these systems. Moreover, noteworthy in this context is the process of neuroinflammation inextricably linked to mitochondria and its impact not only on neurons, but also on glia cells involved in glymphatic clearance. This review only presents possible direct and indirect connections between the glymphatic system and mitochondria in the process of neurodegeneration. Clarifying the connection between these two areas in relation to neurodegeneration could lead to the development of new multidirectional therapies, which, due to the complexity of pathogenesis, seems to be worth considering.

Citing Articles

Nasal lymphatic obstruction of CSF drainage as a possible cause of Alzheimer's disease and dementia.

Phillips W, Schwartz J Front Aging Neurosci. 2024; 16:1482255.

PMID: 39497786 PMC: 11532075. DOI: 10.3389/fnagi.2024.1482255.


Exploring neurodegenerative disorders using advanced magnetic resonance imaging of the glymphatic system.

Prasuhn J, Xu J, Hua J, van Zijl P, Knutsson L Front Psychiatry. 2024; 15:1368489.

PMID: 38651012 PMC: 11033437. DOI: 10.3389/fpsyt.2024.1368489.


Glymphatic System Pathology and Neuroinflammation as Two Risk Factors of Neurodegeneration.

Szlufik S, Kopec K, Szleszkowski S, Koziorowski D Cells. 2024; 13(3.

PMID: 38334678 PMC: 10855155. DOI: 10.3390/cells13030286.


How sleep quality affects activities of daily living in Parkinson's disease: the mediating role of disease severity and the moderating role of cognition.

Luo Y, Liu J, Chen D, Liu M, Yuan Y, Hu J Front Aging Neurosci. 2023; 15:1238588.

PMID: 37842121 PMC: 10570447. DOI: 10.3389/fnagi.2023.1238588.

References
1.
Zhdanova I, Geiger D, Schwagerl A, Leclair O, Killiany R, Taylor J . Melatonin promotes sleep in three species of diurnal nonhuman primates. Physiol Behav. 2002; 75(4):523-9. DOI: 10.1016/s0031-9384(02)00654-6. View

2.
de Leon M, Li Y, Okamura N, Tsui W, Saint-Louis L, Glodzik L . Cerebrospinal Fluid Clearance in Alzheimer Disease Measured with Dynamic PET. J Nucl Med. 2017; 58(9):1471-1476. PMC: 5577629. DOI: 10.2967/jnumed.116.187211. View

3.
Bohnen N, Hu M . Sleep Disturbance as Potential Risk and Progression Factor for Parkinson's Disease. J Parkinsons Dis. 2019; 9(3):603-614. PMC: 6700634. DOI: 10.3233/JPD-191627. View

4.
Muddapu V, Dharshini S, Chakravarthy V, Gromiha M . Neurodegenerative Diseases - Is Metabolic Deficiency the Root Cause?. Front Neurosci. 2020; 14:213. PMC: 7137637. DOI: 10.3389/fnins.2020.00213. View

5.
Galbiati A, Verga L, Giora E, Zucconi M, Ferini-Strambi L . The risk of neurodegeneration in REM sleep behavior disorder: A systematic review and meta-analysis of longitudinal studies. Sleep Med Rev. 2018; 43:37-46. DOI: 10.1016/j.smrv.2018.09.008. View